DarioHealth Corp. (DRIO)

DarioHealth Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-53.78	-63.51	-63.84	-78.77	-33.1	-20.89
Depreciation & Amortization	5.1	4.99	4.72	4.46	0.19	0.18
Share-Based Compensation	21.7	19.7	16.98	24.97	11.1	2.26
Other Operating Activities	-11.76	4.36	-7.34	-3.08	0.42	-0.43
Operating Cash Flow	-38.73	-30.38	-47.85	-50.41	-17.74	-15.73
Capital Expenditures	-0.57	-0.58	-0.44	-0.26	-0.12	-0.1
Acquisitions	-8.8	0	0	-7.47	0	0
Change in Investments	4.33	0.04	0	-0.4	-1.5	-0.02
Other Investing Activities	-	-	-0.13	-	-	-
Investing Cash Flow	-5.04	-0.55	-0.57	-8.13	-1.62	-0.11
Share Issuance / Repurchase	1.61	1.61	38.15	65.77	27.55	25.25
Debt Issued / Paid	3.16	1.77	23.79	0	0	0
Other Financing Activities	35.07	14.87	-	-	-	-
Financing Cash Flow	39.85	18.25	61.94	65.77	27.55	25.25
Net Cash Flow	-3.92	-12.67	13.52	7.22	8.19	9.41
Free Cash Flow	-39.3	-30.96	-48.29	-50.67	-17.85	-15.82
Free Cash Flow Margin	-206.35%	-152.14%	-174.60%	-247.01%	-235.67%	-209.33%
Free Cash Flow Per Share	-1.14	-1.09	-2.04	-3.05	-2.99	-6.98

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).